Addressing Th1/17‐associated immune dysfunction in psoriasis patients enhances the effectiveness of the inactivated <scp>SARS‐CoV</scp>‐2 vaccine-Reference-Cited by-同舟云学术

Addressing Th1/17‐associated immune dysfunction in psoriasis patients enhances the effectiveness of the inactivated SARS‐CoV‐2 vaccine

Published:2023-12-22 Issue: Volume: Page:
ISSN:0926-9959
Container-title:Journal of the European Academy of Dermatology and Venereology
language:en
Short-container-title:Acad Dermatol Venereol

Author:

Ji Chao¹²^ORCID,Zhang Yihua¹,Li Li³,Ruan Shi‐Fan¹,Cai Liangqi⁴,Zhou Kunli⁴,Cai Donghua⁵,Dai Yalan⁵,Lan Jianping⁶,Zhang Liangliang¹,Xu Qiuyun¹,Zou Ying¹,Ke Hui¹,Wu Zhenlan¹,Xiao Zhixun¹,Cheng Bo¹²,Gong Ting⁷,Kang Dezhi⁸^ORCID

Affiliation:

1. Department of Dermatology First Affiliated Hospital of Fujian Medical University Fuzhou Fujian China

2. Key Laboratory of Skin Cancer of Fujian Higher Education institutions Fuzhou Fujian China

3. Department of Health Management Shengli Clinical College of Fujian Medical University, Fujian Provincial Hospital Fuzhou Fujian China

4. Department of Dermatology First Affiliated Hospital of Xiamen University Xiamen Fujian China

5. Department of Dermatology Shishi Municipal General Hospital Quanzhou City China

6. Department of Dermatology Mindong Hospital Affiliated to Fujian Medical University China

7. Central Laboratory First Affiliated Hospital of Fujian Medical University Fuzhou Fujian China

8. Department of Neurosurgery First Affiliated Hospital of Fujian Medical University Fuzhou Fujian China

Funder

National Natural Science Foundation of China

Publisher

Wiley

Subject

Infectious Diseases,Dermatology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/jdv.19654

Reference5 articles.

1. Critical role of interleukin (IL)-17 in inflammatory and immune disorders: An updated review of the evidence focusing in controversies

2. The immunology of atopic dermatitis and its reversibility with broad-spectrum and targeted therapies

3. COVID-19 vaccine safety and efficacy in patients with immune-mediated inflammatory disease: Review of available evidence

4. The effect of methotrexate and targeted immunosuppression on humoral and cellular immune responses to the COVID-19 vaccine BNT162b2: a cohort study

5. Humoral and cellular immunogenicity to a second dose of COVID-19 vaccine BNT162b2 in people receiving methotrexate or targeted immunosuppression: a longitudinal cohort study